Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Mortality of patients with multiple sclerosis: a cohort study in UK primary care.
A computer-based screening method for distress in patients with multiple sclerosis: a feasibility study.
High frequency of antiphospholipid antibodies in relapse of multiple sclerosis: a possible indicator of inflammatory-thrombotic processes.
Multiple sclerosis associated genetic variants of CD226 impair regulatory T cell function.
Cost-Utility of Fingolimod Compared With Dimethyl Fumarate (Dmf) In Highly Active Relapsing Remitting Multiple Sclerosis (Rrms) In England: Comparison of A Markov and Discrete Event Simulation Model.
Interventions to Improve Adherence in Patients with Immune-Mediated Inflammatory Disorders: A Systematic Review.
Cannabinoids and autoimmune diseases: A systematic review.
Multiple sclerosis: overview of disease-modifying agents.
Idiopathic inflammatory demyelinating disease of the central nervous system in patients with inflammatory bowel disease: retrospective analysis of 9095 patients.
B cells and progressive multifocal leukoencephalopathy: search for the missing link.
Effects of walking direction and cognitive challenges on gait in persons with multiple sclerosis.
Novel therapeutic options for multiple sclerosis.
Body mass index during adolescence, rather than childhood, is critical in determining MS risk.
Neocortical Neuronal Loss in Patients with Multiple System Atrophy: A Stereological Study.
condition Specific Utilities: Impact on Icer in a Markov Model for Multiple Sclerosis.
Care Partners and Multiple Sclerosis: Differential Effect on Men and Women.
Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination.
Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception.
Mesenchymal stem cells of dental origin - their potential for anti-inflammatory and regenerative actions in brain and gut damage.
Nurse-led clinics for patients with chronic diseases in hospital and transmural care organizations.
Exercise as a therapy for improvement of walking ability in adults with multiple sclerosis: A meta-analysis.
Seasonality of 278 neuromyelitis optica relapses in a Brazilian cohort.
Development and validation of an administrative data algorithm to estimate the disease burden and epidemiology of multiple sclerosis in Ontario, Canada.
The Role of fMRI to Assess Plasticity of the Motor System in MS.
From Identification to Characterization of the Multiple Sclerosis Susceptibility Gene CLEC16A.
Pages
« first
‹ previous
…
668
669
670
671
672
673
674
675
676
…
next ›
last »